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A corrigendum on
Chronic Pyruvate Supplementation Increases Exploratory Activity and Brain Energy Reserves
in Young and Middle-Aged Mice
by Koivisto, H., Leinonen, H., Puurula, M., Hafez, H. S., Alquicer Barrera, G., Stridh, M. H., et al.
(2016). Front. Aging Neurosci. 8:41. doi: 10.3389/fnagi.2016.00041
In the Original Research article there was an error in the Section “Treatment” under the section
“Methods” about the estimated daily intake of pyruvate:
“With the average food intake of 4 g this corresponds to 800mg of pyruvate/day, which is at the
upper range of effective pyruvate doses in earlier in vivo studies (Suh et al., 2005; Fukushima et al.,
2009; Isopi et al., 2014).”
As correctly stated in the Abstract, the estimated dose was 800mg of pyruvate/kg/day.
The corrected version of this section is shown below:
Treatment
Chronic Pyruvate Administration
The test group (PYR) received experimental chow supplemented with 0.6 % (w) of Na-pyruvate
(Safe Diets, Augy, France). The control group (STD) received the same basic rodent chow (A04, Safe
Diets). With the average food intake of 4 g this corresponds to 800mg of pyruvate/kg/day, which is
at the upper range of effective pyruvate doses in earlier in vivo studies (Suh et al., 2005; Fukushima
et al., 2009; Isopi et al., 2014). Acute pyruvate administration. The mice received Na-pyruvate
(Sigma, St. Louis, MO, USA) 500 mg/kg i.p. or the same molar concentration of NaCl (260 mg/kg
i.p.). This single dose affords neuroprotection against cortical concussion injury and increases
brain glucose and pyruvate levels as measured by in vivo microdialysis (Fukushima et al., 2009).
Koivisto et al. Chronic Pyruvate and Brain Energy
All cage labels about the treatment groups were coded so that the
researchers running behavioral tests or assays on post-mortem
samples were blinded as to the treatment.
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